Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Will the Chemotherapy Market Evolve in Terms of Growth and Size by 2029?
The market for chemotherapy has experienced robust growth over the past few years. It is projected to escalate from $34 billion in 2024 to $37.27 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. Factors such as increasing cancer cases, advancement in diagnosis techniques, innovative drug discovery, active clinical trials, better healthcare access, and awareness campaigns have fueled the growth during the historical period.
Anticipations of a swift escalation are being made for the size of the chemotherapy market in the years to come. An increase to “$60.31 billion by 2029 with a compound annual growth rate (CAGR) of 12.8%” is being projected. This predicted growth for the forecasted years is attributed to various factors such as integration of immunotherapy, incorporation of biosimilars, expansion in emerging markets, genomic profiling, advances in supportive care, and regulatory assistance. Key trends for the forecasted period encompass technological innovations in healthcare, custom-tailored medicine, continued research in oncology, incorporation of artificial intelligence (AI), progress in nanotechnology, and administration of chemotherapy at home.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp
What factors are expected to fuel Chemotherapy market growth in the coming years?
The rise in cancer incidence is predicted to escalate the expansion of the chemotherapy market. The term cancer describes a disorder where some cells in the body multiply unrestrained and migrate to other regions. Chemotherapy involves the use of potent medicinal compounds either in unison or individually to eliminate rapidly multiplying cancer cells. The surge in cancer cases will in turn increase the necessity for chemotherapy. For example, the American Cancer Society Inc., a non-profit health organization located in the US, predicts 1.9 million new cancer diagnoses in the US in 2023, marking a rise from 1.8 million new cases recorded in 2020. In the US, it is projected that there would be 609,820 deaths due to cancer in 2023, in contrast to an estimation of 606,520 Americans dying from cancer in 2020. Hence, the escalating occurrence of cancer is propelling the chemotherapy market.
What Are The Key Findings From The Segmentation Analysis Of The Chemotherapy Market?
The chemotherapy market covered in this report is segmented –
1) By Product Type: Pump, Cannula, Catheter, Other Product Types
2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer
3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs
4) By Route Of Administration: Oral, Intravenous
5) By End User: Hospitals, Research Institutes, Other End Users
Subsegments:
1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps
2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports
3) By Catheter: Chemotherapy Catheters, PICC Lines
4) By Other Product Types: Safety Devices, IV Sets, Administration Sets
What Upcoming Trends Are Expected To Impact The Chemotherapy Market Globally?
Key players in the chemotherapy market are striving to differentiate themselves by developing innovative products such as chemotherapy infusion pumps. These devices administer chemotherapy drugs directly into the bloodstream via an intravenous line, allowing for a gradual and constant drug infusion. One example is Shanghai MicroPort Lifesciences Co. Ltd., which in March 2022, attained approval from China’s National Medical Products Administration (NMPA) to market their AutoEx Chemotherapy Infusion Pump. This pump, used for either continuous or intermittent drug infusion in cancer patients, seeks to sustain optimal drug levels in the blood to enhance treatment efficiency while mitigating undesired side effects. The device comes with a dual CPU control system and an alternate power supply to ensure precise drug delivery, thereby increasing patient comfort and safety during treatment.
What Are The Most Active Companies In The Chemotherapy Market Today?
Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report
Which Regional Markets Are Attracting The Most Investment In Chemotherapy?
North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model